Publications by authors named "Hartwig Steckel"

Claim this Profile
D
Development of High Dose Oseltamivir Phosphate Dry Powder for Inhalation Therapy in Viral Pneumonia.
Shahir Aziz, Regina Scherlieβ, Hartwig Steckel

Pharmaceutics· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Powder flow analysis: A simple method to indicate the ideal amount of lactose fines in dry powder inhaler formulations.
Mats Hertel, Eugen Schwarz, Mirjam Kobler, Sabine Hauptstein, Hartwig Steckel

Int J Pharm· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of high shear mixing on ternary dry powder inhaler formulations.
Mats Hertel, Eugen Schwarz, Mirjam Kobler, Sabine Hauptstein, Hartwig Steckel

Int J Pharm· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nano- and Microstructured model carrier surfaces to alter dry powder inhaler performance.
Niklas Renner, Hartwig Steckel, Nora Urbanetz, Regina Scherließ

Int J Pharm· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applicability of the one-step DVS method for the determination of amorphous amounts for further different hydrophilic and hydrophobic drugs.
Thorsten Müller, Regina Scherließ, Jörg Schiewe, Rüdiger Smal, Claudius Weiler, Hartwig Steckel

Eur J Pharm Biopharm· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of small amorphous amounts in hydrophilic and hydrophobic APIs on storage stability of dry powder inhalation products.
Thorsten Müller, Regina Krehl, Jörg Schiewe, Claudius Weiler, Hartwig Steckel

Eur J Pharm Biopharm· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of low amounts of amorphous content in hydrophobic active pharmaceutical ingredients with dynamic organic vapor sorption.
Thorsten Müller, Jörg Schiewe, Rüdiger Smal, Claudius Weiler, Markus Wolkenhauer, Hartwig Steckel

Eur J Pharm Biopharm· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-precipitation of tobramycin into biomimetically coated orthopedic fixation pins employing submicron-thin seed layers of hydroxyapatite.
Jan H Sörensen, Mirjam Lilja, Maria Åstrand, Torben C Sörensen, Philip Procter, Hartwig Steckel

Curr Drug Deliv· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomechanical and antibacterial properties of Tobramycin loaded hydroxyapatite coated fixation pins.
Jan Henrik Sörensen, Mirjam Lilja, Torben Christian Sörensen, Maria Åstrand, Philip Procter, Hartwig Steckel

J Biomed Mater Res B Appl Biomater· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of urea in solution and pharmaceutical preparations.
Nattakan Panyachariwat, Hartwig Steckel

J Cosmet Sci· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation considerations for dry powder inhalers.
Eike Cordts, Hartwig Steckel

Ther Deliv· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical challenges and regulatory requirements for nasal drug products in europe and the u.s.
Sabrina Trows, Klaus Wuchner, Rene Spycher, Hartwig Steckel

Pharmaceutics· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A model for treating avian aspergillosis: serum and lung tissue kinetics for Japanese quail (Coturnix japonica) following single and multiple aerosol exposures of a nanoparticulate itraconazole suspension.
Chris Rundfeldt, Elżbieta Wyska, Hartwig Steckel, Andrzej Witkowski, Grażyna Jeżewska-Witkowska

Med Mycol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug loading and release of Tobramycin from hydroxyapatite coated fixation pins.
Mirjam Lilja, Jan Henrik Sörensen, Ulrika Brohede, Maria Astrand, Philip Procter, Hartwig Steckel

J Mater Sci Mater Med· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physico-chemical characterisation of surface modified particles for inhalation.
Katharina Stank, Hartwig Steckel

Int J Pharm· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone substitute materials delivering zoledronic acid: physicochemical characterization, drug load, and release properties.
Torben C Sörensen, Jörg Arnoldi, Philip Procter, Bernd Robioneck, Hartwig Steckel

J Biomater Appl· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solvent free fabrication of micro and nanostructured drug coatings by thermal evaporation for controlled release and increased effects.
Eman S Zarie, Viktor Kaidas, Dawit Gedamu, Yogendra K Mishra, Rainer Adelung, Hartwig Steckel

PLoS One· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locally enhanced early bone formation of zoledronic acid incorporated into a bone cement plug in vivo.
Torben C Sörensen, Jörg Arnoldi, Philip Procter, Claudia Beimel, Anders Jönsson, Hartwig Steckel

J Pharm Pharmacol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhalable highly concentrated itraconazole nanosuspension for the treatment of bronchopulmonary aspergillosis.
Chris Rundfeldt, Hartwig Steckel, Holger Scherliess, Elżbieta Wyska, Piotr Wlaź

Eur J Pharm Biopharm· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capabilities and limitations of using powder rheology and permeability to predict dry powder inhaler performance.
Eike Cordts, Hartwig Steckel

Eur J Pharm Biopharm· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational design of a dry powder inhaler: device design and optimisation.
Christian Friebel, Hartwig Steckel, Bernd W Müller

J Pharm Pharmacol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a micro-dosing system for fine powder using a vibrating capillary. Part 2. The implementation of a process analytical technology tool in a closed-loop dosing system.
Xiaolong Chen, Karlheinz Seyfang, Hartwig Steckel

Int J Pharm· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a micro dosing system for fine powder using a vibrating capillary. Part 1: the investigation of factors influencing on the dosing performance.
Xiaolong Chen, Karlheinz Seyfang, Hartwig Steckel

Int J Pharm· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The stable cyclic adenosine monophosphate analogue, dibutyryl cyclo-adenosine monophosphate (bucladesine), is active in a model of acute skin inflammation.
Chris Rundfeldt, Hartwig Steckel, Torben Sörensen, Piotr Wlaź

Arch Dermatol Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physico-chemical aspects of lactose for inhalation.
Xiang Kou, Lai Wah Chan, Hartwig Steckel, Paul W S Heng

Adv Drug Deliv Rev· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis